We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Ceco Environmental
CECO
$4.14B
| $776K | ﹤0.01% |
117,769
+776
| +0.7% | +$4.21K |
|
|
MRNS
2727
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $773K | ﹤0.01% |
76,124
-76,939
| -50% | -$708K |
|
|
HOOK
2728
DELISTED
HOOKIPA Pharma
HOOK
| $772K | ﹤0.01% |
6,642
+2,692
| +68% | +$262K |
|
2729
Cartesian Therapeutics
RNAC
$268M
| $771K | ﹤0.01% |
+9,049
| New | +$820K |
|
2730
X4 Pharmaceuticals
XFOR
$460M
| $771K | ﹤0.01% |
2,756
+1,294
| +89% | +$354K |
|
|
SNCR
2731
DELISTED
Synchronoss Technologies
SNCR
| $770K | ﹤0.01% |
24,236
+3,412
| +16% | +$94.1K |
|
|
MCBC
2732
DELISTED
Macatawa Bank Corp
MCBC
| $769K | ﹤0.01% |
98,322
-2,970
| -3% | -$21.5K |
|
2733
CorMedix
CRMD
$584M
| $768K | ﹤0.01% |
121,916
-66,009
| -35% | -$306K |
|
2734
Accuray
ARAY
$34M
| $766K | ﹤0.01% |
377,218
-79,939
| -17% | -$166K |
|
2735
Pure Cycle
PCYO
$261M
| $766K | ﹤0.01% |
83,381
+12,080
| +17% | +$118K |
|
2736
Red River Bancshares
RRBI
$659M
| $764K | ﹤0.01% |
17,398
+9,650
| +125% | +$377K |
|
|
CTO
2737
CTO Realty Growth
CTO
$815M
| $759K | ﹤0.01% |
70,718
-33,182
| -32% | -$366K |
|
2738
Business First Bancshares
BFST
$1.03B
| $757K | ﹤0.01% |
49,305
+7,068
| +17% | +$95.5K |
|
2739
IDEAYA Biosciences
IDYA
$3.56B
| $755K | ﹤0.01% |
+53,131
| New | +$419K |
|
2740
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $754K | ﹤0.01% |
37,510
-42,656
| -53% | -$866K |
|
2741
AXT Inc
AXTI
$5.8B
| $753K | ﹤0.01% |
158,279
+14,254
| +10% | +$67.2K |
|
2742
KORU Medical Systems
KRMD
$164M
| $750K | ﹤0.01% |
+83,435
| New | +$843K |
|
2743
Comscore
SCOR
$109M
| $750K | ﹤0.01% |
12,096
+836
| +7% | +$50.1K |
|
2744
Southern First Bancshares
SFST
$600M
| $750K | ﹤0.01% |
27,060
| – | – |
|
|
CSTR
2745
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $750K | ﹤0.01% |
62,549
+15,161
| +32% | +$164K |
|
2746
Fortress Biotech
FBIO
$88.7M
| $746K | ﹤0.01% |
+18,548
| New | +$689K |
|
|
PLYM
2747
DELISTED
Plymouth Industrial REIT
PLYM
| $742K | ﹤0.01% |
+57,902
| New | +$768K |
|
|
TPCO
2748
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $741K | ﹤0.01% |
74,141
-40,940
| -36% | -$367K |
|
|
IHC
2749
DELISTED
Independence Holding Company
IHC
| $739K | ﹤0.01% |
24,172
+3,622
| +18% | +$101K |
|
2750
Alpha Pro Tech
APT
$53.1M
| $738K | ﹤0.01% |
+41,709
| New | +$576K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.